홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
RANI
#3426
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-0.72%
월간 변동
-0.72%
6달 변화
+140.35%
년간 변동율
-8.67%
이전 종가
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
양
19
마켓
주식
헬스케어
RANI
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
29.81 M
33.51 M
33.57 M
47.9 M
97.54 M
—
Valuation ratios
Enterprise value
—
312.74 M
—
67.23 M
121.43 M
—
Price to earnings ratio
-1.21
-1.3
-1.21
-0.53
-0.58
-3.62
Price to sales ratio
—
0.04
—
—
0.01
—
Price to cash flow ratio
-1.43
-1.1
-1.05
-0.5
-0.59
-3.24
Price to book ratio
2.13
19.58
6.23
-7.85
-1.3
16.66
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.16
0.24
0.3
0.4
0.53
1.48
Return on equity %
1.17
2.56
1.36
0.73
0.45
5.1
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
100
100
—
—
—
Operating margin %
—
1 454.96
6 984.3
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
870.33
4 223.26
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.6
1.5
0.88
0.54
0.26
3.17
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
0.03
0.01
0
0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0.31
0.26
0.25
0.13
0
0.64
Long term debt to total equity ratio
4.34
4.83
1.94
0.4
0
7.16
Per share metrics
Operating cash flow per share
0.31
0.3
0.24
0.16
0.11
0.81
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.16
0.13
0.3
0.28
0.09
0.8
Net current asset value per share
1.2
1.04
0.53
0.3
0.11
1.99
Tangible book value per share
0.11
0.07
0.09
0.15
0.17
0.48
Working capital per share
0.45
0.35
-0.07
-0.26
-0.31
-0.29
Book value per share
0.12
0.07
0.09
0.15
0.17
0.48
뉴스
라니 테라퓨틱스, 알리레자 자바디 CTO로 승진
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics, 의결권 축소 및 세금 계약 종료
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani, 쥬가이 제약과 10억 8,500만 달러 규모 협력
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Rani Therapeutics 이사, 16억 원 상당 주식 매입
Rani Therapeutics director Imran Mir a buys $1.26 million in stock
Rani Therapeutics, 이사 임명 및 사모 자금 조달 마감